10:33 AM EDT, 09/18/2025 (MT Newswires) -- Illumina ( ILMN ) and Nashville Biosciences said Thursday that Alnylam Pharmaceuticals ( ALNY ) has joined the Alliance for Genomic Discovery.

Alnylam will use the alliance's genomic database to boost drug target discovery, the companies said.

Alnylam is the ninth member of the alliance joining AbbVie ( ABBV ) , Amgen ( AMGN ) , AstraZeneca ( AZN ) , Bayer, Bristol Myers Squibb ( BMY ) , GSK (GSK), Merck ( MRK ) , and Novo Nordisk ( NVO ) , the companies said.

Price: 103.16, Change: +2.29, Percent Change: +2.27